CLAIMS DATA ANALYSIS OF PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) IN GERMANY

被引：0
|
作者：
Bartsch, R. [1 ]
Zimmermann, L. [2 ]
Reis, L. [1 ]
Hecker, D. [3 ]
Lebioda, A. [3 ]
机构：
[1] Amgen GmbH, Munich, Germany
[2] Gesundheitsforen Leipzig GmbH, Leipzig, Germany
[3] Amgen GmbH, Munich, Germany
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN177
引用
收藏
页码：S453 / S453
页数：1
相关论文
共 50 条
  • [21] INDIGENOUS PATIENTS AND METASTATIC COLORECTAL CANCER: RESULTS FROM THE SOUTH AUSTRALIAN (SA) METASTATIC COLORECTAL CANCER (MCRC) REGISTRY
    Hocking, Chris
    Karapetis, Christos
    Beeke, Carol
    Priest, Kevin
    Roder, David
    Padbury, Robert
    Maddern, Guy
    Price, Timothy J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 132 - 132
  • [22] Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data
    Oppelt, Katja Anita
    Luttmann, Sabine
    Kraywinkel, Klaus
    Haug, Ulrike
    BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)
  • [23] Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data
    Katja Anita Oppelt
    Sabine Luttmann
    Klaus Kraywinkel
    Ulrike Haug
    BMC Medical Research Methodology, 19
  • [24] Characteristics and treatment effect of senior patients with metastatic colorectal cancer (mCRC): A retrospective analysis.
    Boudreault, J.
    Tehfe, M. A.
    Aubin, F.
    Sylvestre, M.
    Ayoub, J. M.
    Richard, C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Liver Only Metastatic Disease in Patients With Metastatic Colorectal Cancer (mCRC), Impact of Surgery and Chemotherapy
    Bishnoi, S.
    Price, T.
    Beeke, C.
    Karapetis, C.
    Townsend, A.
    Maddern, G.
    Padbury, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S403 - S403
  • [26] The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)
    Akbulut, H.
    Ocal, M.
    Sonugur, G.
    Akay, B.
    Babahan, C.
    Abgarmi, S. Abdi
    Demirkazik, A.
    Icli, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [28] A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC)
    Krakowska, M.
    Debska-Szmich, S.
    Czernek, U.
    Czyzykowski, R.
    Potemski, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 9 - 10
  • [29] Nationwide survey on patients' and professionals' expectations on prognosis of metastatic colorectal cancer (mCRC)
    Sailas, L.
    Kataja, V.
    Kuoppala, J.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S50 - S50
  • [30] Tumor burden (TB) as a prognostic indicator in patients with metastatic colorectal cancer (mCRC).
    Loh, Kiley Wei Jen
    Shapiro, Jeremy David
    Tran, Ben
    Wong, Hui-Li
    Wong, Shu Fen
    Richardson, Gary Edward
    Harold, Michael
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345